Overview
- Goodburn, who was diagnosed in 2024 with multiple low‑grade, inoperable brain tumours, qualified for and finished equal‑seventh in the men's 50m breaststroke final at the Commonwealth Games on Monday.
- He has secured access to the experimental drug vorasidenib after campaigning, and he and reports say the treatment has slowed tumour growth and delayed the need for chemotherapy.
- After the final Goodburn spoke emotionally about campaigning for better research funding and urged the UK government to create a national brain cancer lead to co‑ordinate care and research.
- While training and competing he completed a first‑class chemical engineering degree at Edinburgh University and has drawn strong public and team support at Tollcross.
- Advocates and coverage note brain cancer remains the biggest cancer killer of people under 40 in the UK, and Goodburn’s platform may increase pressure for policy change and more clinical trials for young patients.